ACETILCISTEINA 600 mg Tabletka Musująca
Ocena recepty online
Lekarz przeanalizuje Twój przypadek i zdecyduje, czy wystawienie recepty jest medycznie uzasadnione.
Porozmawiaj z lekarzem o tym leku
Omów swoje objawy i opcje leczenia podczas szybkiej konsultacji online.
Jak stosować AKETILKISTEINA TSENTIVA LAB
Treść ulotki
ACETILCISTEINA ZENTIVA LAB 600 mg effervescent tablets
N-acetylcysteine
Generic medicine
Read this leaflet carefully before you start taking this medicine as it contains
important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
- If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Contents of this leaflet:
- 1. What ACETILCISTEINA ZENTIVA LAB is and what it is used for
- 2. What you need to know before you take ACETILCISTEINA ZENTIVA LAB
- 3. How to take ACETILCISTEINA ZENTIVA LAB
- 4. Possible side effects
- 5. How to store ACETILCISTEINA ZENTIVA LAB
- 6. Contents of the pack and other information
1. What is ACETILCISTEINA ZENTIVA LAB and what is it used for
ACETILCISTEINA ZENTIVA LAB contains the active ingredient acetylcysteine, which belongs to a
group of medicines called mucolytics, used to facilitate the elimination of mucus from the
respiratory tract and to a group of medicines called antidotes used to counteract the toxic effect of
certain substances.
ACETILCISTEINA ZENTIVA LAB is indicated for the treatment of diseases of the
respiratory system characterized by an increase in the production of dense and viscous mucus (dense and viscous hypersecretion) such as:
- inflammation of the bronchi (acute bronchitis, chronic bronchitis and its exacerbations);
- pathology of the pulmonary alveoli (pulmonary emphysema);
- cystic fibrosis (mucoviscidosis);
- bronchial dilations (bronchiectasis). ACETILCISTEINA ZENTIVA LAB is used as an antidote in particular for:
- accidental or intentional poisoning with paracetamol, an anti-inflammatory medicine;
- pathology affecting the urinary tract (uropathy) caused by chemotherapeutic drugs such as ifosfamide and cyclophosphamide.
2. What you need to know before taking ACETILCISTEINA ZENTIVA LAB
Do not take ACETILCISTEINA ZENTIVA LAB:
- if you are allergic to N-acetylcysteine or any of the other ingredients of this medicine (listed in section 6);
- if you are pregnant or breastfeeding unless after careful evaluation by your doctor (See section “Pregnancy and breastfeeding”).
Warnings and precautions
Talk to your doctor or pharmacist before taking ACETILCISTEINA ZENTIVA LAB.
Take this medicine with caution and always under the control of your doctor in the following cases:
- if you suffer from an inflammatory disease of the bronchi called bronchial asthma. Immediately stop taking ACETILCISTEINA ZENTIVA LAB if you have bronchospasm (contraction of the bronchial muscles). Also consult your doctor if these disorders have occurred in the past;
- if you are intolerant to histamine; allergic reactions (hypersensitivity) may occur if taking ACETILCISTEINA ZENTIVA LAB;
- if you suffer from or have suffered from a problem with your stomach or intestines called peptic ulcer, especially if you are taking other medicines with ACETILCISTEINA ZENTIVA LAB that can cause stomach problems (gastrolesive drugs). This medicine may increase the volume of bronchial mucus (bronchial secretions), especially at the beginning of treatment. Therefore, if this occurs and you are unable to eliminate the bronchial secretions by coughing (expectorating), consult your doctor who will indicate a method for eliminating the mucus (postural drainage or bronchoaspiration). If you notice a sulfur odor, do not worry as this does not indicate alteration of the preparation, but is due to N-acetylcysteine. Laboratory tests: N-acetylcysteine may interfere with some blood and urine tests (colorimetric dosage for the determination of salicylates and tests to determine ketones). Inform your doctor that you are taking this medicine before undergoing these tests.
Other medicines and ACETILCISTEINA ZENTIVA LAB
Tell your doctor or pharmacist if you are taking, have recently taken or might take
any other medicine.
Do not take this medicine if you are taking:
- cough medicines (antitussives), because they can lead to an accumulation of mucus inside the bronchi. Take this medicine with caution and consult your doctor if you are taking any of the following medicines:
- activated charcoal used to treat digestive disorders or to eliminate intestinal gas (flatulence), because it can reduce the effectiveness of ACETILCISTEINA ZENTIVA LAB;
- medicines used for the treatment of infections (antibiotics) taken orally (with the exception of loracarbef). Take these medicines at least two hours apart from ACETILCISTEINA ZENTIVA LAB;
- nitroglycerin, used for some heart conditions. The simultaneous use of this medicine with ACETILCISTEINA ZENTIVA LAB may cause a decrease in blood pressure (hypotension) and headache. In this case, your doctor will monitor you closely.
Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant, are planning a pregnancy, or are breastfeeding with
breast milk, ask your doctor or pharmacist for advice before taking this medicine.
Take this medicine if you are pregnant or breastfeeding only if strictly necessary
and under the direct supervision of your doctor.
Driving and using machines
ACETILCISTEINA ZENTIVA LAB does not affect the ability to drive vehicles and use
machinery.
ACETILCISTEINA ZENTIVA LAB contains sodium
This medicine contains 194 mg of sodium (the main component of table salt) per
tablet. This is equivalent to 9.7% of the maximum recommended daily intake with the diet of
an adult.
3. How to take ACETILCISTEINA ZENTIVA LAB
Take this medicine following exactly the instructions of your doctor or pharmacist. If you
have any doubts, consult your doctor or pharmacist.
Treatment of respiratory diseases
The recommended dose is 1 tablet (600 mg) per day, preferably in the evening. Your doctor may
advise you to modify the frequency and dose of administration but without exceeding the maximum
daily dose of 600 mg.
The duration of therapy in acute forms ranges from 5 to 10 days and in chronic forms, the doctor will evaluate
whether to continue therapy, for several months.
Treatment of accidental or intentional poisoning with paracetamol
The recommended initial dose is 140 mg of N-acetylcysteine per kg of body weight, to be
administered as soon as possible, within 10 hours of taking paracetamol. Subsequently the dose
is 70 mg of N-acetylcysteine per kg of body weight at intervals of 4 hours for 1-3 days.
Treatment of pathology affecting the urinary tract (uropathy) caused by chemotherapeutic
drugs such as ifosfamide and cyclophosphamide
The recommended dose is 4 g of N-acetylcysteine per day to be divided into 4 doses of 1 g, in patients
undergoing a chemotherapy cycle with ifosfamide and cyclophosphamide for 5 days every 28 days.
Instructions for use of ACETILCISTEINA ZENTIVA LAB
Dissolve one tablet in a glass containing water, stirring if necessary with a teaspoon, and
drink the solution without letting it rest. Do not mix other medicines with the Acetilcysteine
EPharma Trento solution.
If you take more ACETILCISTEINA ZENTIVA LAB than you should
No cases of overdose have been reported. Symptoms of overdose may include nausea,
vomiting and diarrhea.
In case of ingestion/taking an excessive dose of this medicine, immediately inform your
doctor or go to the nearest hospital.
If you forget to take ACETILCISTEINA ZENTIVA LAB
Do not take a double dose to make up for a missed dose.
If you have any doubts about the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur:
Uncommon(may affect up to 1 in 100 people)
- allergic reactions (hypersensitivity);
- headache;
- ringing in the ears (tinnitus);
- increased heart rate (tachycardia);
- vomiting;
- diarrhea;
- inflammation of the mouth (stomatitis);
- abdominal pain;
- nausea;
- urticaria, rash;
- swelling of the face, lips, mouth, tongue or throat which may cause difficulty swallowing or breathing (angioedema);
- itching;
- fever;
- low blood pressure. Rare(may affect up to 1 in 1,000 people)
- constriction of the bronchial muscles (bronchospasm);
- difficulty breathing (dyspnea);
- digestive difficulties (dyspepsia).
Very rare(may affect up to 1 in 10,000 people)
- severe allergic reactions (anaphylactic shock, anaphylactic/anaphylactoid reaction);
- bleeding (hemorrhage).
Not known(frequency cannot be estimated from available data)
- swelling (edema) of the face.
In very rare cases, severe skin reactions (Stevens-Johnson syndrome or Lyell's syndrome) have occurred. If you experience changes in the mucous membranes or skin, stop taking the medicine and
consult your doctor.
Also consult your doctor if you experience prolonged bleeding time (reduced
platelet aggregation).
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your
doctor or pharmacist. You can also report side effects directly through
the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-
avverse. By reporting side effects you can help provide more information on
the safety of this medicine.
5. How to store ACETILCISTEINA ZENTIVA LAB
Keep this medicine out of the sight and reach of children.
Keep the tube tightly closed to protect the medicine from light and moisture.
This medicine does not require any particular storage temperature.
Do not use this medicine after the expiry date which is stated on the cardboard box after
EXP. The expiry date refers to the last day of that month.
After the first opening of the tube, store the medicine at a temperature below 25°C, for a period
of 3 months.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What ACETILCISTEINA ZENTIVA LAB contains
- The active ingredient is acetylcysteine: 1 effervescent tablet contains 600 mg of acetylcysteine.
- The other ingredients are: citric acid, maltodextrins, sodium bicarbonate, orange aroma, leucine, sodium saccharin.
Description of the appearance of ACETILCISTEINA ZENTIVA LAB and contents of the pack
ACETILCISTEINA ZENTIVA LAB 600 mg is presented in the form of effervescent tablets
packaged in tubes of 15 tablets.
The pack contains 30 tablets, contained in 2 tubes of 15 tablets.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder: ZENTIVA ITALIA S.R.L.
VIALE LUIGI BODIO, 37/B, 20158 MILANO
Manufacturer: E-Pharma Trento S.p.A., via Provina 2, 38123 Trento (TN).
Nie jesteś pewien, czy ten lek jest odpowiedni dla ciebie?
Omów swoje objawy i leczenie z lekarzem online.
Zacząłeś przyjmować lek i masz pytania?
Omów swoje objawy i leczenie z lekarzem online.
- Kraj rejestracji
- Postać farmaceutycznaEffervescent tablet, 600 MG
- Kod ATCR05CB01
- Substancja czynna
- Wymaga receptyTak
- Producent
- Te treści mają charakter wyłącznie informacyjny i nie zastępują konsultacji lekarskiej.
- Zamienniki AKETILKISTEINA TSENTIVA LABPostać farmaceutyczna: Injectable solution, 300 MG/3 MLSubstancja czynna: acetylcysteineProducent: SANDOZ S.P.A.Wymaga receptyPostać farmaceutyczna: Powder for oral solution, 100 MGSubstancja czynna: acetylcysteineProducent: SANDOZ S.P.A.Bez receptyPostać farmaceutyczna: Oral solution powder, 600 MGSubstancja czynna: acetylcysteineProducent: HEXAL A/SWymaga recepty
Odpowiedniki AKETILKISTEINA TSENTIVA LAB w innych krajach
Leki z tą samą substancją czynną dostępne w innych krajach.
Odpowiednik AKETILKISTEINA TSENTIVA LAB w Hiszpania
Odpowiednik AKETILKISTEINA TSENTIVA LAB w Polska
Odpowiednik AKETILKISTEINA TSENTIVA LAB w Ukraina
Lekarze online w sprawie AKETILKISTEINA TSENTIVA LAB
Omów stosowanie AKETILKISTEINA TSENTIVA LAB, bezpieczeństwo i ocenę zasadności recepty zgodnie z obowiązującymi przepisami.
Uzyskaj receptę na AKETILKISTEINA TSENTIVA LAB online
Wypełnij 2-minutowy formularz
Opisz swoje objawy, historię choroby i lek, o który prosisz.
Wybierz lekarza lub pozwól nam przydzielić
Wybierz specjalistę lub dopasujemy Cię do najbliższego dostępnego lekarza.
Lekarz analizuje Twój przypadek
Zazwyczaj w ciągu 30 minut. Może zadawać dodatkowe pytania przez czat.
Odbierz w dowolnej aptece
Recepta elektroniczna wysłana na Twój e-mail — ważna w całej Polsce.
Często zadawane pytania
AKETILKISTEINA TSENTIVA LAB wymaga recepty w Włochy. Możesz skonsultować się z lekarzem online, aby sprawdzić, czy ten lek może być odpowiedni w Twojej sytuacji.
Substancją czynną w AKETILKISTEINA TSENTIVA LAB jest acetylcysteine. Informacja ta pomaga rozpoznać leki o tym samym składzie, ale pod różnymi nazwami handlowymi.
AKETILKISTEINA TSENTIVA LAB jest produkowany przez ZENTIVA ITALIA S.R.L.. Nazwy handlowe i opakowania mogą się różnić w zależności od dystrybutora.
Lekarze, tacy jak Lekarze rodzinni, Psychiatrzy, Dermatolodzy, Kardiolodzy, Endokrynolodzy, Gastroenterolodzy, Pulmonolodzy, Nefrolodzy, Reumatolodzy, Hematolodzy, Zakaźnicy, Alergolodzy, Geriatrzy, Pediatrzy, Onkolodzy, mogą ocenić, czy stosowanie AKETILKISTEINA TSENTIVA LAB jest odpowiednie w Twoim przypadku, w zależności od sytuacji klinicznej i lokalnych przepisów. Możesz umówić konsultację online, aby omówić objawy i możliwe dalsze kroki.
Polska posiada dobrze rozwiniętą infrastrukturę ochrony zdrowia w dużych miastach, takich jak Warszawa, Kraków, Wrocław i Gdańsk. Apteki są łatwo dostępne i działają zgodnie z obowiązującymi przepisami, zapewniając dostęp do leków na receptę.
Możesz kupić AKETILKISTEINA TSENTIVA LAB w Warszawie, Krakowie, Wrocławiu lub Gdańsku w każdej aptece, posiadając ważną receptę.
Aby uzyskać receptę, możesz skorzystać z Oladoctor:
Inne leki zawierające tę samą substancję czynną (acetylcysteine) to m.in. AKK FLUIDIFIKANTE E ANTIDOTO, AKK, AKKFLUBUST. Mogą one różnić się nazwą handlową lub postacią, ale zawierają ten sam składnik terapeutyczny. Przed zmianą lub rozpoczęciem nowego leku skonsultuj się z lekarzem.
